Skip to content

Infectious Disease Funding-Addition to Primary List

Advancing Cancer Immunotherapy by Mitigating Immune-related Adverse Events (irAEs) (U01 Clinical Trial Not Allowed)

United States Department of Health and Human Services (HHS)

National Institutes of Health (NIH)

25 Apr 2019

$1,875,000 USD

Leave a Reply

Your email address will not be published. Required fields are marked *